McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authored a September 2018 DDN News article entitled, “Patent Docs: Allergan, a Mohawk tribe and the USPTO.” One of the most controversial patent application strategies in recent memory is Allergan’s attempt to avoid inter partes review (IPRs) of several of its patents protecting its Restasis product franchise. view the article
